Dr. Jamie Fettig, Cancer pharmacogenetics expert, discusses breakthroughs in eliminating variants of unknown significance in pharmacogenetics and companion diagnostic tests in oncology. They explore the importance of personalized medicine and genetic testing for effective drug selection in treating different types of cancers. The episode also highlights advancements in genetic technology, the potential of pharmacogenetics in creating custom drugs, and the balance between quality and quantity in cancer assay testing.